Systemic vasculitis--is it time to reclassify? by Watts, R, Suppiah, R, Merkel, P, Luqmani, R

Assessment of damage in vasculitis: Expert ratings of damage by Seo, P, Jayne, DR, Luqmani, R, Merkel, P

Assessment of damage in vasculitis: expert ratings of damage. by Seo, P, Jayne, D, Luqmani, R, Merkel, P

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes by Robson, J, Jayne, D, Merkel, P, Dawson, J

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis by Pearce, F, Craven, A, Merkel, P, Luqmani, R, Watts, R

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). by Luqmani, R, Suppiah, R, Grayson, P, Merkel, P, Watts, R

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis by Pearce, F, Craven, A, Merkel, P, Luqmani, R, Watts, R

Assembly and qualification procedures of CMS forward pixel detector modules by Koybasi, O, Arndt, K, Bolla, G, Bortoletto, D, Merkel, P, Shipsey, I

Cutaneous manifestations of ANCA-associated vasculitis by Chiesafuxench, Z, Micheletti, R, Luqmani, R, Watts, R, Craven, A, Merkel, P

Pulmonary manifestations of primary systemic vasculitides by Makhzoum, J, Luqmani, R, Watts, R, Craven, A, Merkel, P, Pagnoux, C

Assessment of damage in vasculitis: expert ranking of items of damage by Seo, P, Jayne, D, Luqmani, R, Merkel, P, Consortium, VCR, Grp, E

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease by Micheletti, R, Chiesa, Z, Craven, A, Watts, R, Luqmani, R, Merkel, P

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis by Monti, S, Leong, A, Robson, J, Craven, A, Merkel, P, Watts, R, Luqmani, R

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS by Monti, S, Leong, A, Robson, J, Craven, A, Merkel, P, Watts, R, Luqmani, R

The frequency and severity of patient-reported symptoms in giant cell arteritis by Monti, S, Leong, A, Robson, J, Craven, A, Merkel, P, Watts, R, Luqmani, R

Modified Birmingham vasculitis activity score for Wegener's granulomatosis (BVAS/WG) - Construct validity. by Maiden, N, Luqmani, R, Uhlfelder, M, Merkel, P, Hoffman, G, Stone, J, Investigators, INSSYS

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. by Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR

O08 Blindness in patients with giant cell arteritis and its association with vascular disease by Yates, M, Macgregor, A, Robson, J, Craven, A, Merkel, P, Luqmani, R, Watts, R

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. by Merkel, P, Herlyn, K, Mahr, A, Neogi, T, Seo, P, Walsh, M, Boers, M, Luqmani, R

The association of vascular risk factors with visual loss in giant cell arteritis by Yates, M, MacGregor, A, Robson, J, Craven, A, Merkel, P, Luqmani, R, Watts, R